Elsol Pharmaceutical Private Limited

Elsol Pharmaceutical Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24100MH2015PTC262521 Incorporated 05 March 2015 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹4.78 Lakh
▼ 32% YoY
Net loss · FY 2025
₹39,644
Net margin -8.3%
EBITDA · FY 2025
-₹37,816
EBITDA margin -7.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Elsol Pharmaceutical Private Limited

Data last updated:

Elsol Pharmaceutical Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 March 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2015PTC262521. Its GSTIN is 10AADCE8913A1ZC (Bihar).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mitu Kumari (Managing Director) and Amar Nath.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.78 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net loss of ₹39,644 (net margin -8.3%) and EBITDA of -₹37,816 (EBITDA margin -7.9%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 23% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100MH2015PTC262521
Registration Number 262521
Incorporation Date 05 March 2015
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Elsol Pharmaceutical Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Regus Business Center Mumbai Pvt Ltd Dev Corpora 15 Floor Pokhran Road No.1 Eastern Exp, . Highway, Thane, Maharashtra, India – 400601
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Elsol Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Elsol Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Elsol Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Elsol Pharmaceutical Private Limited, buy the company report.

Financials of Elsol Pharmaceutical Private Limited

FY 2025 filings available

Elsol Pharmaceutical Private Limited reported revenue of ₹4.78 Lakh (down 32% YoY) for FY 2025.

Revenue · FY 2025
₹4.78 Lakh ▼ 32%
Net loss · FY 2025
₹39,644 margin -8.3%
EBITDA · FY 2025
-₹37,816 margin -7.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 19%
5 years · compounded
▼ 23%
EBITDA CAGR growth
1 year
▼ 279%
3 years · compounded
▼ 39%
5 years · compounded
▼ 22%

Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 32% fall in the latest year. EBITDA fell 279% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹37,816
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹39,644
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-7.9%
Net Profit Margin-8.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Elsol Pharmaceutical Private Limited, buy the company report.

Board of directors of Elsol Pharmaceutical Private Limited

Elsol Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mitu KumariManaging Director25 Mar 20179 Years 7 MonthsCurrent
Amar NathDirector05 Mar 201511 Years 7 MonthsCurrent

Peer comparison

Elsol Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Tripler Trade and Industries Private Limited₹4.95 Lakh (FY 2025)-87.0%Chennai, Tamil Nadu, India
Mangla Pharmaceuticals Private Limited₹4.92 Lakh (FY 2025)Lakhimpur, Uttar Pradesh, India
Chemiken Healthcare Private Limited₹4.9 Lakh (FY 2025)31.0%Bangalore, Karnataka, India
Lairus Pharma Private Limited₹4.82 Lakh (FY 2024)22247.0%Nashik, Maharashtra, India
Redmarck Drugs Private Limited₹4.81 Lakh (FY 2025)2174.0%Varanasi, Uttar Pradesh, India
Elsol Pharmaceutical Private Limitedthis company₹4.78 Lakh (FY 2025)-₹39,644-8.3%-32.0%Thane, Maharashtra, India
Intraunique Healthcare Private Limited₹4.65 Lakh (FY 2025)Palghar, Maharashtra, India
Millifluous Pharmaceuticals Private Limited₹4.56 Lakh (FY 2024)New Delhi, Delhi, India
Thene Pharmaceutical Private Limited₹4.33 Lakh (FY 2025)206.0%Hyderabad, Telangana, India
Yspin Pharmaceuticalprivate Limited₹4.26 Lakh (FY 2025)4.0%Faizabad, Uttar Pradesh, India
MCCG India Private Limited₹4.1 Lakh (FY 2025)Kolkata, West Bengal, India

To see the full peer comparison of Elsol Pharmaceutical Private Limited, buy the company report.

Auditor

Elsol Pharmaceutical Private Limited is audited by THAKURDILIPKUMAR & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
THAKURDILIPKUMAR & ASSOCIATESFY 2017326574E

Shareholding

The shareholding of Elsol Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Elsol Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Elsol Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Elsol Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AADCE8913A1ZCBiharActive01 Jul 2017

To see the full GST registrations and return filing status of Elsol Pharmaceutical Private Limited, buy the company report.

Recent activity

Elsol Pharmaceutical Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Mitu Kumari ceased to be Additional Director on 05 Nov 2017.

AGM
Elsol Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elsol Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Mitu Kumari ceased to be Additional Director.
Ceased
Bharat Bhushan Kumar ceased to be Director.
Appointed
Mitu Kumari was appointed as Managing Director.
Ceased
Komal Arora ceased to be Director.
Appointed
Amar Nath was appointed as Director.
Incorporation
05 Mar 2015
Elsol Pharmaceutical Private Limited was registered on 05 Mar 2015 with Roc Mumbai Ii & aged 11 years 7 months as per MCA records.

Frequently asked questions

Elsol Pharmaceutical is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 March 2015 (11+ years old) and is registered under CIN U24100MH2015PTC262521.

Elsol Pharmaceutical has 2 current directors:

The latest financial statements of Elsol Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Elsol Pharmaceutical is 10AADCE8913A1ZC, registered in Bihar.

The CIN (Corporate Identification Number) of Elsol Pharmaceutical is U24100MH2015PTC262521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elsol Pharmaceutical was incorporated on 05 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Elsol Pharmaceutical by revenue are Tripler Trade and Industries Private Limited, Mangla Pharmaceuticals Private Limited, Chemiken Healthcare Private Limited, Lairus Pharma Private Limited, Redmarck Drugs Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).

Mitu Kumari ceased to be Additional Director on 05 Nov 2017. Bharat Bhushan Kumar ceased to be Director on 31 Mar 2017. Mitu Kumari was appointed as Managing Director on 25 Mar 2017. Elsol Pharmaceutical has 5 board changes on record in total.

The registered office of Elsol Pharmaceutical is at Regus Business Center Mumbai Pvt Ltd Dev Corpora 15 Floor Pokhran Road No.1 Eastern Exp, . Highway, Thane, Maharashtra, India – 400601.

Elsol Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Elsol Pharmaceutical is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.